Skip navigation

Huadong Medicine Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$3,655
Revenue Growth (%)16.81%
Net Income (US$ Millions)$208
Earnings Per Share (US$)$0.43
EPS Growth Rate (%)18.58%
Profit Margin5.70%
Total Equity (US$ Millions)$1,048
Return on Equity (%)48.69%
Long Term Debt (US$ Millions)$146
Debt To Equity Ratio (%)0.14%
Total Assets (US$ Millions)$2,082
Current Assets (US$ Millions)$1,686
Current Liabilities (US$ Millions)$833
Cost of Goods Sold (US$ Millions)$2,768
Inventory Turnover4.85